Vanguard Group’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.1M Buy
1,609,918
+63,301
+4% +$514K ﹤0.01% 2758
2025
Q1
$10.9M Buy
1,546,617
+15,964
+1% +$112K ﹤0.01% 2800
2024
Q4
$11.4M Buy
1,530,653
+215,437
+16% +$1.6M ﹤0.01% 2886
2024
Q3
$6.48M Buy
1,315,216
+25,208
+2% +$124K ﹤0.01% 3163
2024
Q2
$6.62M Buy
1,290,008
+105,152
+9% +$539K ﹤0.01% 3124
2024
Q1
$6.29M Sell
1,184,856
-165,711
-12% -$880K ﹤0.01% 3201
2023
Q4
$8.36M Hold
1,350,567
﹤0.01% 3054
2023
Q3
$10.2M Hold
1,350,567
﹤0.01% 2864
2023
Q2
$13.1M Sell
1,350,567
-114,117
-8% -$1.1M ﹤0.01% 2798
2023
Q1
$5.53M Buy
1,464,684
+190,815
+15% +$720K ﹤0.01% 3255
2022
Q4
$8.25M Buy
1,273,869
+5,770
+0.5% +$37.4K ﹤0.01% 3040
2022
Q3
$11.3M Sell
1,268,099
-3,488
-0.3% -$31K ﹤0.01% 2903
2022
Q2
$12.7M Sell
1,271,587
-58,313
-4% -$581K ﹤0.01% 2860
2022
Q1
$15.4M Buy
1,329,900
+72,064
+6% +$835K ﹤0.01% 2921
2021
Q4
$14M Sell
1,257,836
-182,219
-13% -$2.02M ﹤0.01% 3042
2021
Q3
$13.3M Buy
1,440,055
+42,060
+3% +$388K ﹤0.01% 3086
2021
Q2
$15.7M Sell
1,397,995
-281,169
-17% -$3.16M ﹤0.01% 2959
2021
Q1
$17.8M Buy
1,679,164
+7,323
+0.4% +$77.6K ﹤0.01% 2846
2020
Q4
$18.1M Sell
1,671,841
-406,673
-20% -$4.41M ﹤0.01% 2687
2020
Q3
$20.2M Buy
2,078,514
+395,645
+24% +$3.85M ﹤0.01% 2455
2020
Q2
$13.4M Sell
1,682,869
-188,002
-10% -$1.5M ﹤0.01% 2623
2020
Q1
$16.3M Buy
1,870,871
+251,769
+16% +$2.19M ﹤0.01% 2383
2019
Q4
$18.3M Sell
1,619,102
-134,045
-8% -$1.52M ﹤0.01% 2578
2019
Q3
$19.1M Sell
1,753,147
-59,336
-3% -$645K ﹤0.01% 2516
2019
Q2
$17M Buy
1,812,483
+218,927
+14% +$2.05M ﹤0.01% 2592
2019
Q1
$19.6M Sell
1,593,556
-10,365
-0.6% -$127K ﹤0.01% 2515
2018
Q4
$19M Buy
1,603,921
+68,404
+4% +$810K ﹤0.01% 2466
2018
Q3
$22.1M Buy
1,535,517
+63,494
+4% +$914K ﹤0.01% 2535
2018
Q2
$21.9M Buy
1,472,023
+64,740
+5% +$965K ﹤0.01% 2526
2018
Q1
$18.4M Buy
1,407,283
+51,019
+4% +$666K ﹤0.01% 2535
2017
Q4
$17.1M Buy
1,356,264
+30,159
+2% +$380K ﹤0.01% 2554
2017
Q3
$17.2M Buy
1,326,105
+32,539
+3% +$421K ﹤0.01% 2553
2017
Q2
$19.2M Buy
1,293,566
+38,572
+3% +$573K ﹤0.01% 2474
2017
Q1
$15.1M Buy
1,254,994
+49,191
+4% +$590K ﹤0.01% 2570
2016
Q4
$16.6M Buy
1,205,803
+30,265
+3% +$418K ﹤0.01% 2500
2016
Q3
$15.8M Buy
1,175,538
+4,703
+0.4% +$63.1K ﹤0.01% 2473
2016
Q2
$12.6M Buy
1,170,835
+68,400
+6% +$736K ﹤0.01% 2538
2016
Q1
$11.6M Buy
1,102,435
+108,412
+11% +$1.14M ﹤0.01% 2534
2015
Q4
$11.8M Sell
994,023
-22,420
-2% -$265K ﹤0.01% 2552
2015
Q3
$11.9M Buy
1,016,443
+193,548
+24% +$2.26M ﹤0.01% 2515
2015
Q2
$11.9M Buy
822,895
+9,894
+1% +$143K ﹤0.01% 2580
2015
Q1
$11.3M Sell
813,001
-22,547
-3% -$315K ﹤0.01% 2587
2014
Q4
$11.5M Buy
835,548
+3,163
+0.4% +$43.7K ﹤0.01% 2480
2014
Q3
$10.2M Buy
832,385
+41,356
+5% +$507K ﹤0.01% 2487
2014
Q2
$9.88M Buy
791,029
+38,048
+5% +$475K ﹤0.01% 2509
2014
Q1
$8.4M Buy
752,981
+45,497
+6% +$508K ﹤0.01% 2568
2013
Q4
$8.58M Buy
707,484
+34,474
+5% +$418K ﹤0.01% 2537
2013
Q3
$8.21M Buy
673,010
+6,400
+1% +$78.1K ﹤0.01% 2486
2013
Q2
$8.81M Buy
+666,610
New +$8.81M ﹤0.01% 2387